Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05275920 · ClinicalTrials.gov registry record · NA
Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure (BETTER CARE-HF)
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 2,211
- Enrollment target
NCT05275920 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 2,211 participants.
The verdict
NCT05275920, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,211 participants
- Enrollment target
Study Summary
Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure (BETTER CARE-HF) is a pragmatic, cluster-randomized, three-arm intervention trial that will compare the effectiveness of two targeted clinical decision support (CDS) intervention tools (best practice alert (BPA) and automated in-basket massage) to inform providers when a patient with heart failure and reduce ejection fraction (HFrEF) is not on appropriate medical therapy, as compared to usual care.
Interventions
- OTHER Best Practice Alert (BPA)
- OTHER In-Basket Message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,211 participants |
| Start Date | 2022-04-28 |
| Est. Completion | 2022-10-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05275920
The ClinicalTrials.gov registry entry for NCT05275920 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,211 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Best Practice Alert (BPA) is the first listed.
NCT05275920 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05275920 about?
NCT05275920 is a clinical study titled "Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure (BETTER CARE-HF)". Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure (BETTER CARE-HF) is a pragmatic, cluster-randomized, three-arm intervention trial that will compare the effectiveness of two targeted clinical decision support (CDS) intervention tools (best practice al...
What is the current status of trial NCT05275920?
This trial is currently completed. It is a NA study. The enrollment target is 2,211 participants. The study started on 2022-04-28. Estimated completion is 2022-10-26.
What interventions are being tested in trial NCT05275920?
The interventions under investigation include: Best Practice Alert (BPA) (OTHER), In-Basket Message (OTHER).
Who is sponsoring clinical trial NCT05275920?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.